You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

zanubrutinib

Showing 26 - 50 of 66
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Thrombocytopenia, Treatment Trial in Tianjin (Zanubrutinib)

Recruiting
  • Immune Thrombocytopenia
  • Treatment
  • Zanubrutinib
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Jan 19, 2022

Immune Thrombocytopenia Trial (Zanubrutinib, Dexamethasone)

Not yet recruiting
  • Immune Thrombocytopenia
  • (no location specified)
May 6, 2022

B-cell Malignancies Trial in Australia (Zanubrutinib, Fluconazole, Diltiazem)

Completed
  • B-cell Malignancies
  • Zanubrutinib
  • +4 more
  • Concord, New South Wales, Australia
  • +6 more
Jul 18, 2022

Immune Thrombocytopenia Trial in Beijing (Zanubrutinib, Eltrombopag)

Not yet recruiting
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
May 6, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Zanubrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma
  • Boston, Massachusetts
  • +2 more
Mar 16, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Leukemia (SLL) Trial in United States (Zanubrutinib, Obinutuzumab,

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Leukemia (SLL)
  • Zanubrutinib
  • +2 more
  • Evanston, Illinois
  • +7 more
Sep 9, 2022

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial in Houston (Rituximab, Zanubrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  • Rituximab
  • Zanubrutinib
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

Diffuse Large B Cell Lymphoma, CD79A Gene Mutation, CD79B Gene Mutation Trial in Zhengzhou (Rituximab, Zanubrutinib,

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jan 22, 2022

Diffuse Large B Cell Lymphoma Trial in Shanghai (zanubrutinib)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • zanubrutinib
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 13, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Follicular Lymphoma Trial in Australia, China (BGB-10188,

Recruiting
  • Chronic Lymphocytic Leukemia
  • +9 more
  • Adelaide, Australia
  • +12 more
Jan 6, 2023

Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Nanjing, Nanjin (Zanubrutinib, Lenalidomide, Rituximab)

Recruiting
  • Non Hodgkin Lymphoma
  • Diffuse Large B Cell Lymphoma
  • Zanubrutinib
  • +6 more
  • Nanjing, Jiangsu, China
  • +1 more
Mar 9, 2022

Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Transformed Chronic

Not yet recruiting
  • Recurrent Transformed Chronic Lymphocytic Leukemia
  • +7 more
  • Biospecimen Collection
  • +9 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 15, 2023

Richter Transformation Trial in Austria, Denmark, Germany (Tislelizumab, Zanubrutinib)

Recruiting
  • Richter Transformation
  • Tislelizumab
  • Zanubrutinib
  • Vienna, Austria
  • +11 more
Mar 8, 2022

Healthy, Male Trial in Daytona Beach (Zanubrutinib, Rifabutin)

Completed
  • Healthy
  • Male
  • Daytona Beach, Florida
    Covance Clinical Research Unit
Aug 30, 2021

Lymphoma, Leukemia Trial in Australia, China (Zanubrutinib, Tislelizumab)

Completed
Has Results
  • Lymphoma
  • Leukemia
  • Darlinghurst, New South Wales, Australia
  • +9 more
Mar 16, 2022

Primary Vitreoretinal Lymphoma Trial in Beijing (Methotrexate, Rituximab, Zanubrutinib)

Recruiting
  • Primary Vitreoretinal Lymphoma
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 19, 2021

B-cell Lymphoma Trial in China (Zanubrutinib)

Completed
Has Results
  • B-cell Lymphoma
  • Zanubrutinib
  • Beijing, Beijing, China
  • +3 more
Sep 26, 2021

COVID-19 Pulmonary Complications, COVID-19 Trial in United States (Zanubrutinib, Supportive Care, Placebo)

Completed
Has Results
  • COVID-19 Pulmonary Complications
  • COVID-19
  • Zanubrutinib
  • +2 more
  • Scottsdale, Arizona
  • +17 more
Feb 25, 2022

Relapsed Diffuse Large B-cell Lymphoma, Refractory Diffuse Large B-cell Lymphoma Trial in China (Zanubrutinib)

Recruiting
  • Relapsed Diffuse Large B-cell Lymphoma
  • Refractory Diffuse Large B-cell Lymphoma
  • Zanubrutinib
  • Hefei, Anhui, China
  • +21 more
Mar 2, 2022

Non-GCB/ABC DLBCL Trial in Suzhou (Zanubrutinib, Rituximab, Cyclophosphamide)

Recruiting
  • Non-GCB/ABC Diffuse Large B-Cell Lymphoma
  • Zanubrutinib
  • +5 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Apr 12, 2021

Relapsed/Refractory DLBCL Trial in China (Zanubrutinib, Lenalidomide)

Recruiting
  • Relapsed/Refractory Diffuse Large B-Cell Lymphoma
  • Beijing, Beijing, China
  • +9 more
Aug 11, 2021

Primary Mediastinal Large B Cell Lymphoma, EBV-Positive DLBCL, Nos Trial in Shanghai (Zanubrutinib, Tislelizumab)

Recruiting
  • Primary Mediastinal Large B Cell Lymphoma
  • EBV-Positive DLBCL, Nos
  • Shanghai, Shanghai, China
    Ruijin Hospital
Mar 29, 2021

Chronic Lymphoid Leukemia Trial in Germany (Bendamustine, Obinutuzumab, Zanubrutinib)

Recruiting
  • Chronic Lymphoid Leukemia
  • Aachen, Germany
  • +20 more
Oct 5, 2021

DLBCL, Transformed Follicular Lymphoma to DLBCL, Transformed Marginal Zone Lymphoma to DLBCL Trial in Columbus

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 23, 2022

Diffuse Large B-cell Lymphoma Trial in China (Zanubrutinib)

Completed
Has Results
  • Diffuse Large B-cell Lymphoma
  • Zanubrutinib
  • Beijing, Beijing, China
  • +10 more
Oct 11, 2021